Find a Physician | Courier | Events Calendar | About Us | Clinical Trials
ASH Updates:   Current Trends in Leukemia, Lymphoma and Myeloma On-line registration is now closed.
Please register in person
starting 8:00 a.m. on Feb 28.

Friday, February 28, 2014

8:00 a.m. - 12:45 p.m.

Northwestern Memorial Hospital
Prentice Women's Hospital
250 E Superior St
Conference Room L
Google Map

On Friday, February 28, 2014, the Lurie Cancer Center and Northwestern University Feinberg School of Medicine will host ASH Updates: Current Trends in Leukemia, Lymphoma and Myeloma. This symposium will provide updates on treatment options that can be integrated into the treatments of patients with various hematologic malignancies as well as enhance awareness of novel agents in development in order to increase the number of patients enrolled in clinical trials.

Conference Chair

Dr Gordon
Leo Gordon, MD
Abby and John Friend Professor of Oncology Research
Lurie Cancer Center
Feinberg School of Medicine
Northwestern University


8:00 a.m. Registration & Continental Breakfast
8:30 a.m. Welcome & Opening Remarks

Leo Gordon, MD
Professor, Hematology/Oncology

8:45 a.m. Lymphoma Update

Adam Petrich, MD
Assistant Professor, Hematology/Oncology

9:30 a.m. Leukemia Update

Jessica Altman, MD
Associate Professor, Hematology/Oncology
Shira Dinner, MD
Assistant Professor, Hematology/Oncology

10:15 a.m. Benign Hematologic Disorders Update

Brandon J McMahon, MD
Assistant Professor, Hematology/Oncology

11:00 a.m. Boxed Lunch & Exhibits
11:15 a.m. Myeloma Update

Jayesh Mehta, MD
Professor, Hematology/Oncology

12:00 p.m. MDS and Myeloproliferative Disorders Update

Brady Stein, MD
Assistant Professor, Hematology/Oncology

* All speakers are members of Northwestern University.


Target Audience

Medical oncologists and hematologists interested in the treatment of patients with hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals.

Conference Objectives

  • Outline new developments in the identification of predictive and prognostic biomarkers that provide the rationale for choosing specific treatment strategies in various hematologic malignancies
  • Summarize new data that might influence current treatment and monitoring strategies for patients with newly diagnosed leukemia, lymphoma, and myeloma
  • Evaluate the safety and efficacy of recent clinical advances relative to standards of care in the management of patients with relapsed/refactory leukemia, lymphoma and myeloma
  • Assess the efficacy and safety of emerging novel agents for the treatment of patients with leukemia, lymphoma, myeloma and benign hematologic disorders
  • Evaluate the current role of hematopoietic stem cell transplantation in outcomes for patients with hematologic malignancies

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure

Northwestern University Feinberg School of Medicine requires course directors, speakers, instructors, planners and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by NUFSM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty disclosures and the discussion off-label usage will be indicated in the course syllabus.


Daily discounted parking is available at the 321 E. Erie Self-Park Garage (corner of Erie St. & Fairbanks Ct). The early-bird flat rate is $15 if you arrive between 5 a.m. and 9:30 a.m. and depart by 7:30 p.m. Discounted parking is not available at any other garage.

Please be aware that there is construction work taking place which has closed Erie to through traffic between St Clair and Fairbanks Court. Please consult this map for alternate routes to the garage.

Additional Information

For additional information, please contact Megan Cahill, manager of Education Programs, or call 312.695.1391.

Sponsored by
Feinberg School of Medicine